Article Name Hospital & Healthcare
The US Food and Drug Administration (FDA) approval in December 2023, of two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of a rare disease called sickle cell disease (SCD) in patients 12 years and older, is a huge development. With rare diseases posing significant challenges due to the scarcity of information, limited research, and insufficient awareness among healthcare professionals and the public, introduction and approval of specific treatments can provide a much needed boost to tackle the growing burden of rare diseases globally. However, an integrated approach with enhanced coordination and cooperation across the ecosystem is the need of the hour.
28th February, 2024
Siriraj Hospital's Commitment to Comprehensive Cancer Care
26th February, 2024
Tucson Medical Center Implants First Patient with Novel Investigational Device
26th February, 2024
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
22nd February, 2024
First-ever installation in Fortis Hospital, Bengaluru
21st February, 2024
American Lung Association releases report detailing health benefits for children of transition to zero-emission vehicles and electricity
21st March, 2024
GALI™ SonR® CRT-D and NAVIGO™ 4LV Pacing Leads Launch Set to Enhance Heart Failure Management and Patient Safety
19th February, 2024
Establishing a comprehensive "AI-assisted Physician" using generative AI from Google Cloud, including MedLM
19th February, 2024
Supporting Employee Well-Being: Boston Scientific's Mental Health Benefits
16th February, 2024
On 15th of every month, leading Medanta Cardiac Experts and community based Practitioners will join LIVE on Social Media Channels to discuss on advanced Cardiac health related topics and the state-of-the-art technology, which can be used for cardiac care.
14th February, 2024
Advancing Critical Care: Ruby Hall Clinic Unveils State-of-the-Art ICU Facility
14th February, 2024
Hcgmcc Draws Patients From Across The Globe For Safe, Effective Economical Treatment
13th February, 2024
Advancing Understanding in Pulsed Field Ablation with Biosense Webster
09th February, 2024
New joint venture creates pathway for introducing UltraSight's technology to Korean market
06th February, 2024
CARDIOVIT® FT-2 is SCHILLER’s answer to the highest hospital demands. We are proud to announce our brand-new hospital ECG device CARDIOVIT® FT-2.
06th February, 2024
Thyrocare Expands Healthcare Portfolio with Acquisition of Think Health Diagnostics, Paving the Way for Convenient At-Home ECG Services
05th February, 2024
"A robust governance framework, well-defined standards and policies critical to an effective response system. · AI, telehealth, digital transformation and telematics are increasingly playing a critical role in managing disaster situations" explains Dr Al Ali, EMS and Disaster Medicine at the Department of Health Abu Dhabi
01st February, 2024
The medical technology company takes visitors on a voyage of discovery across the healthcare industry, shedding light on access to healthcare and patient pathways
30th January, 2024
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer